TRANSMEDICS GROUP INC (TMDX) Stock Fundamental Analysis
USA - NASDAQ:TMDX - US89377M1099 - Common Stock
119.15 USD
+4.86 (+4.25%)
119.15 USD
0 (0%)
We assign a fundamental rating of 6 out of 10 to TMDX. TMDX was compared to 191 industry peers in the Health Care Equipment & Supplies industry. TMDX has only an average score on both its financial health and profitability. TMDX is not priced too expensively while it is growing strongly. Keep and eye on this one! These ratings could make TMDX a good candidate for growth investing.
1. Profitability
1.1 Basic Checks
In the past year TMDX was profitable.
In the past year TMDX had a positive cash flow from operations.
TMDX had negative earnings in 4 of the past 5 years.
TMDX had negative operating cash flow in 4 of the past 5 years.
1.2 Ratios
TMDX's Return On Assets of 8.05% is amongst the best of the industry. TMDX outperforms 91.10% of its industry peers.
The Return On Equity of TMDX (22.53%) is better than 94.76% of its industry peers.
The Return On Invested Capital of TMDX (7.25%) is better than 83.25% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.05% | ||
| ROE | 22.53% | ||
| ROIC | 7.25% |
ROA(3y)-4.07%
ROA(5y)-12.78%
ROE(3y)-7.35%
ROE(5y)-22.97%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With an excellent Profit Margin value of 13.49%, TMDX belongs to the best of the industry, outperforming 89.53% of the companies in the same industry.
TMDX's Operating Margin of 14.41% is amongst the best of the industry. TMDX outperforms 84.29% of its industry peers.
The Gross Margin of TMDX (59.79%) is better than 60.21% of its industry peers.
In the last couple of years the Gross Margin of TMDX has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.41% | ||
| PM (TTM) | 13.49% | ||
| GM | 59.79% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.32%
GM growth 5Y0.21%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so TMDX is destroying value.
The number of shares outstanding for TMDX has been increased compared to 1 year ago.
The number of shares outstanding for TMDX has been increased compared to 5 years ago.
The debt/assets ratio for TMDX has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 5.00 indicates that TMDX is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 5.00, TMDX is doing good in the industry, outperforming 78.53% of the companies in the same industry.
The Debt to FCF ratio of TMDX is 29.44, which is on the high side as it means it would take TMDX, 29.44 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 29.44, TMDX is doing good in the industry, outperforming 68.06% of the companies in the same industry.
TMDX has a Debt/Equity ratio of 1.61. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of TMDX (1.61) is worse than 82.20% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.61 | ||
| Debt/FCF | 29.44 | ||
| Altman-Z | 5 |
ROIC/WACC0.92
WACC7.92%
2.3 Liquidity
TMDX has a Current Ratio of 9.86. This indicates that TMDX is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 9.86, TMDX belongs to the top of the industry, outperforming 92.15% of the companies in the same industry.
A Quick Ratio of 9.10 indicates that TMDX has no problem at all paying its short term obligations.
TMDX has a better Quick ratio (9.10) than 91.62% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 9.86 | ||
| Quick Ratio | 9.1 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 4725.00% over the past year.
TMDX shows a strong growth in Revenue. In the last year, the Revenue has grown by 48.09%.
Measured over the past years, TMDX shows a very strong growth in Revenue. The Revenue has been growing by 79.64% on average per year.
EPS 1Y (TTM)4725%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%162.86%
Revenue 1Y (TTM)48.09%
Revenue growth 3Y144.36%
Revenue growth 5Y79.64%
Sales Q2Q%37.68%
3.2 Future
Based on estimates for the next years, TMDX will show a very strong growth in Earnings Per Share. The EPS will grow by 49.75% on average per year.
TMDX is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 21.19% yearly.
EPS Next Y138.21%
EPS Next 2Y66.18%
EPS Next 3Y53.31%
EPS Next 5Y49.75%
Revenue Next Year39.73%
Revenue Next 2Y29.87%
Revenue Next 3Y25.77%
Revenue Next 5Y21.19%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
TMDX is valuated quite expensively with a Price/Earnings ratio of 61.74.
TMDX's Price/Earnings ratio is a bit cheaper when compared to the industry. TMDX is cheaper than 67.02% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.20. TMDX is valued rather expensively when compared to this.
TMDX is valuated quite expensively with a Price/Forward Earnings ratio of 42.72.
TMDX's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. TMDX is cheaper than 70.16% of the companies in the same industry.
TMDX is valuated expensively when we compare the Price/Forward Earnings ratio to 22.71, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 61.74 | ||
| Fwd PE | 42.72 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of TMDX indicates a somewhat cheap valuation: TMDX is cheaper than 69.11% of the companies listed in the same industry.
67.54% of the companies in the same industry are more expensive than TMDX, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 234.08 | ||
| EV/EBITDA | 39.94 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
TMDX's earnings are expected to grow with 53.31% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.45
PEG (5Y)N/A
EPS Next 2Y66.18%
EPS Next 3Y53.31%
5. Dividend
5.1 Amount
TMDX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
119.15
+4.86 (+4.25%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners121.6%
Inst Owner Change-6.21%
Ins Owners2.98%
Ins Owner Change2.28%
Market Cap4.06B
Analysts81.25
Price Target149.43 (25.41%)
Short Float %25.01%
Short Ratio7.39
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)133.71%
Min EPS beat(2)100.04%
Max EPS beat(2)167.38%
EPS beat(4)3
Avg EPS beat(4)55.99%
Min EPS beat(4)-59.86%
Max EPS beat(4)167.38%
EPS beat(8)6
Avg EPS beat(8)145.25%
EPS beat(12)10
Avg EPS beat(12)114.95%
EPS beat(16)11
Avg EPS beat(16)83.13%
Revenue beat(2)2
Avg Revenue beat(2)9.07%
Min Revenue beat(2)4.34%
Max Revenue beat(2)13.8%
Revenue beat(4)3
Avg Revenue beat(4)4.75%
Min Revenue beat(4)-7.28%
Max Revenue beat(4)13.8%
Revenue beat(8)7
Avg Revenue beat(8)11.77%
Revenue beat(12)11
Avg Revenue beat(12)15.17%
Revenue beat(16)14
Avg Revenue beat(16)17.24%
PT rev (1m)-2.98%
PT rev (3m)9.33%
EPS NQ rev (1m)-0.06%
EPS NQ rev (3m)13.11%
EPS NY rev (1m)30.57%
EPS NY rev (3m)33.88%
Revenue NQ rev (1m)0.01%
Revenue NQ rev (3m)2.85%
Revenue NY rev (1m)3.19%
Revenue NY rev (3m)3.59%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 61.74 | ||
| Fwd PE | 42.72 | ||
| P/S | 7.65 | ||
| P/FCF | 234.08 | ||
| P/OCF | 35.24 | ||
| P/B | 12.77 | ||
| P/tB | 13.34 | ||
| EV/EBITDA | 39.94 |
EPS(TTM)1.93
EY1.62%
EPS(NY)2.79
Fwd EY2.34%
FCF(TTM)0.51
FCFY0.43%
OCF(TTM)3.38
OCFY2.84%
SpS15.58
BVpS9.33
TBVpS8.93
PEG (NY)0.45
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.05% | ||
| ROE | 22.53% | ||
| ROCE | 9.18% | ||
| ROIC | 7.25% | ||
| ROICexc | 13.96% | ||
| ROICexgc | 14.41% | ||
| OM | 14.41% | ||
| PM (TTM) | 13.49% | ||
| GM | 59.79% | ||
| FCFM | 3.27% |
ROA(3y)-4.07%
ROA(5y)-12.78%
ROE(3y)-7.35%
ROE(5y)-22.97%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.32%
GM growth 5Y0.21%
F-Score7
Asset Turnover0.6
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.61 | ||
| Debt/FCF | 29.44 | ||
| Debt/EBITDA | 5.09 | ||
| Cap/Depr | 412.74% | ||
| Cap/Sales | 18.43% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 114.93% | ||
| Profit Quality | 24.21% | ||
| Current Ratio | 9.86 | ||
| Quick Ratio | 9.1 | ||
| Altman-Z | 5 |
F-Score7
WACC7.92%
ROIC/WACC0.92
Cap/Depr(3y)951.97%
Cap/Depr(5y)615.69%
Cap/Sales(3y)34.99%
Cap/Sales(5y)23.68%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4725%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%162.86%
EPS Next Y138.21%
EPS Next 2Y66.18%
EPS Next 3Y53.31%
EPS Next 5Y49.75%
Revenue 1Y (TTM)48.09%
Revenue growth 3Y144.36%
Revenue growth 5Y79.64%
Sales Q2Q%37.68%
Revenue Next Year39.73%
Revenue Next 2Y29.87%
Revenue Next 3Y25.77%
Revenue Next 5Y21.19%
EBIT growth 1Y6324.25%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year292.7%
EBIT Next 3Y89.1%
EBIT Next 5Y68.38%
FCF growth 1Y142.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y451.66%
OCF growth 3YN/A
OCF growth 5YN/A